Ovid Therapeutics
OVID
OVID
49 hedge funds and large institutions have $77.2M invested in Ovid Therapeutics in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.44% more ownership
Funds ownership: 29.36% → 31.8% (+2.4%)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.18M | |
| 2 | +$3.43M | |
| 3 | +$1.58M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$450K |
| 5 |
Morgan Stanley
New York
|
+$181K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$1.27M | |
| 3 | -$1.15M | |
| 4 |
Jennison Associates
New York
|
-$821K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$775K |